Overcoming immune evasion with innovative multi-target approaches for glioblastoma

被引：0
|
作者：
Su, Hai [1 ]
Peng, Yin [1 ]
Wu, Yilong [1 ]
Zeng, Xiaoli [2 ,3 ,4 ]
机构：
[1] Chongqing Med Univ, Dept Neurosurg, Yongchuan Hosp, Chongqing, Peoples R China
[2] Gannan Med Univ, Affiliated Hosp 1, Dept Oncol, Ganzhou, Jiangxi, Peoples R China
[3] Gannan Med Univ, Affiliated Hosp 1, Jiangxi Flagship Oncol Dept Synergy Chinese & West, Ganzhou, Jiangxi, Peoples R China
[4] Gannan Med Univ, Affiliated Hosp 1, Jiangxi Clin Med Res Ctr Canc, Dept Oncol, Ganzhou, Jiangxi, Peoples R China
来源：
FRONTIERS IN IMMUNOLOGY | 2025年 / 16卷
关键词：
glioblastoma; immune evasion; immunotherapy; PD-1; immune checkpoint; TUMOR-INFILTRATING LYMPHOCYTES; RANDOMIZED PHASE-III; REGULATORY T-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; RECURRENT GLIOBLASTOMA; INHIBITORY MOLECULES; CHECKPOINT BLOCKADE; UP-REGULATION; GLIOMA; EXPRESSION;
D O I：
10.3389/fimmu.2025.1541467
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Glioblastoma (GBM) cells leverage complex endogenous and environmental regulatory mechanisms to drive proliferation, invasion, and metastasis. Tumor immune evasion, facilitated by a multifactorial network, poses a significant challenge to effective therapy, as evidenced by the limited clinical benefits of monotherapies, highlighting the adaptive nature of immune evasion. This review explores glioblastoma's immune evasion mechanisms, the role of ICIs in the tumor microenvironment, and recent clinical advancements, offering theoretical insights and directions for monotherapy and combination therapy in glioblastoma management.
引用
收藏
页数：8
相关论文
共 50 条
  • [1] OVERCOMING IMMUNE EVASION IN GLIOBLASTOMA
    Simonds, Erin
    Lu, Edbert
    McHenry, Lauren
    Chuntova, Pavlina
    Okada, Hideho
    Weiss, William
    Hellstrom, Mats
    NEURO-ONCOLOGY, 2018, 20 : 121 - 122
  • [2] Multi-Target Approaches in Metabolic Syndrome
    Lillich, Felix F.
    Imig, John D.
    Proschak, Ewgenij
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [3] VISTA: A promising target for overcoming immune evasion in gynecologic cancers
    Liu, Sicong
    Ji, Feng
    Ding, Yue
    Ding, Bo
    Feng, Songwei
    Brennick, Cory
    Lin, Hao
    Zhang, Tianxiang
    Shen, Yang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 138
  • [4] In-Silico Approaches to Multi-target Drug DiscoveryComputer Aided Multi-target Drug Design, Multi-target Virtual Screening
    Xiao Hua Ma
    Zhe Shi
    Chunyan Tan
    Yuyang Jiang
    Mei Lin Go
    Boon Chuan Low
    Yu Zong Chen
    Pharmaceutical Research, 2010, 27 (5) : 739 - 749
  • [5] Editorial: Experimental and Innovative Approaches to Multi-Target Treatment of Parkinson's and Alzheimer's Diseases
    Tikhonova, Maria A.
    Chang, Hung-Ming
    Singh, Sandeep Kumar
    Vieau, Didier
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [6] Artificial learning approaches for multi-target tracking
    Blount, D
    Kouritzin, M
    McCrosky, J
    AUTOMATIC TARGET RECOGNITION XIV, 2004, 5426 : 293 - 304
  • [7] Overcoming Immune Evasion in Melanoma
    Eddy, Kevinn
    Chen, Suzie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (23) : 1 - 48
  • [8] Systematic Discovery of Novel Multi-Target Therapies for Glioblastoma Multiforme
    Lee, Margaret S.
    Johansen, Lisa M.
    Magid, Omar
    Nolan, Garry
    Wilson, Amy
    Nichols, M. James
    Zimmermann, Grant R.
    Keith, Curtis T.
    CANCER RESEARCH, 2006, 66 (08)
  • [9] Immune Evasion Strategies of Glioblastoma
    Razavi, Seyed-Mostafa
    Lee, Karen E.
    Jin, Benjamin E.
    Aujla, Parvir S.
    Gholamin, Sharareh
    Li, Gordon
    FRONTIERS IN SURGERY, 2016, 3
  • [10] Fast Data Association Approaches for Multi-target Tracking
    Zhang, Yaotian
    Yang, Yifeng
    Wei, Shaoming
    Wang, Jun
    2016 CIE INTERNATIONAL CONFERENCE ON RADAR (RADAR), 2016,
12345